The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations - PubMed (original) (raw)
doi: 10.1055/s-2004-817972.
A Fritsche, L M t'Hart, J Machann, C Thamer, O Tschritter, T W Van Haeften, S Jacob, J M Dekker, J A Maassen, F Machicao, F Schick, R J Heine, H Häring
Affiliations
- PMID: 15146371
- DOI: 10.1055/s-2004-817972
The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations
M Stumvoll et al. Exp Clin Endocrinol Diabetes. 2004 May.
Abstract
The peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) is involved in regulation of fatty acid oxidation, skeletal muscle fiber type specificity, and gluconeogenesis. The prevalent Gly482Ser variant in PGC-1 was shown to be associated with type 2 diabetes in some but not all studies. Moreover, it is unclear whether it influences prediabetic subphenotypes in non-diabetic populations. We studied the association of this variant with glucose tolerance (oral glucose tolerance test), insulin sensitivity (euglycemic hyperinsulinemic clamp) of glucose disposal and antilipolysis, insulin secretion (hyperglycemic clamp, 10 mM), maximal oxygen consumption (VO(2)max, bicycle ergometry), and intramyocellular lipids (magnetic resonance spectroscopy, tibialis and soleus muscle) in a normal glucose tolerant German cohort (n = 423) and a normal (n = 65) and impaired glucose tolerant (n = 94) cohort from the Netherlands. No statistically significant association with an examined phenotype was detected in any of the study cohorts. Specifically, VO(2)max and the soleus-to-tibialis ratio of intramyocellular lipid contents as a surrogate parameter of fiber type specificity was not different between the genotype groups. We conclude, that the Gly482Ser variant in PGC-1 is not associated with diabetes-related traits or skeletal muscle fiber type composition in a non-diabetic German and Dutch population.
Similar articles
- Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Ek J, et al. Diabetologia. 2001 Dec;44(12):2220-6. doi: 10.1007/s001250100032. Diabetologia. 2001. PMID: 11793024 - Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome.
Vohl MC, Houde A, Lebel S, Hould FS, Marceau P. Vohl MC, et al. Mol Genet Metab. 2005 Sep-Oct;86(1-2):300-6. doi: 10.1016/j.ymgme.2005.07.002. Mol Genet Metab. 2005. PMID: 16122961 - The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
Fanelli M, Filippi E, Sentinelli F, Romeo S, Fallarino M, Buzzetti R, Leonetti F, Baroni MG. Fanelli M, et al. Dis Markers. 2005;21(4):175-80. doi: 10.1155/2005/576748. Dis Markers. 2005. PMID: 16403952 Free PMC article. - Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.
Horiki M, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, Shimamoto K, Ogihara T. Horiki M, et al. Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S63-7. doi: 10.1016/j.diabres.2003.09.023. Diabetes Res Clin Pract. 2004. PMID: 15563983 - [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Wang C, Zhai F, Chi Y, Wang G. Wang C, et al. Wei Sheng Yan Jiu. 2004 May;33(3):317-20. Wei Sheng Yan Jiu. 2004. PMID: 15211802 Chinese.
Cited by
- Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity.
Andersen G, Wegner L, Yanagisawa K, Rose CS, Lin J, Glümer C, Drivsholm T, Borch-Johnsen K, Jørgensen T, Hansen T, Spiegelman BM, Pedersen O. Andersen G, et al. J Med Genet. 2005 May;42(5):402-7. doi: 10.1136/jmg.2004.026278. J Med Genet. 2005. PMID: 15863669 Free PMC article. - PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.
Finck BN, Kelly DP. Finck BN, et al. J Clin Invest. 2006 Mar;116(3):615-22. doi: 10.1172/JCI27794. J Clin Invest. 2006. PMID: 16511594 Free PMC article. Review. - PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.
Cantó C, Auwerx J. Cantó C, et al. Curr Opin Lipidol. 2009 Apr;20(2):98-105. doi: 10.1097/MOL.0b013e328328d0a4. Curr Opin Lipidol. 2009. PMID: 19276888 Free PMC article. Review. - Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.
Bailén M, Tabone M, Bressa C, Lominchar MGM, Larrosa M, González-Soltero R. Bailén M, et al. Genes (Basel). 2022 Feb 1;13(2):289. doi: 10.3390/genes13020289. Genes (Basel). 2022. PMID: 35205333 Free PMC article. - THE PPARGC1A - GLY482SER POLYMORPHISM (RS8192678) AND THE METABOLIC SYNDROME IN A CENTRAL ROMANIAN POPULATION.
Csép K, Szigeti E, Vitai M, Korányi L. Csép K, et al. Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):161-167. doi: 10.4183/aeb.2017.161. Acta Endocrinol (Buchar). 2017. PMID: 31149168 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical